









市場
/
株式
/
nasdaq-ogn
/

Organon & Co

OGN

7.185USD

+0.095+1.34%

終値 12/26, 16:00（ET）15分遅れの株価

1.87B時価総額

3.72直近12ヶ月PER



Organon & Co

7.185

+0.095+1.34%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Organon & Co 企業名

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Organon & Coの企業情報



企業コードOGN

会社名Organon & Co

上場日May 14, 2021

最高経営責任者「CEO」Morrissey (Joseph T)

従業員数10000

証券種類Ordinary Share

決算期末May 14

本社所在地30 Hudson Street

都市JERSEY CITY

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国United States of America

郵便番号07302

電話番号15514306000

ウェブサイトhttps://www.organon.com/

企業コードOGN

上場日May 14, 2021

最高経営責任者「CEO」Morrissey (Joseph T)

Organon & Coの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Matthew M. (Matt) Walsh

Chief Financial Officer, Executive Vice President

144.48K

+8.57%

Ms. Rachel A. Stahler

Executive Vice President, Chief Digital and Growth Officer

71.89K

+18.29%

Mr. Aaron Falcione

Chief Human Resources Officer, Executive Vice President

59.92K

+10.11%

Mr. Kirke Weaver

Executive Vice President, General Counsel, Corporate Secretary

52.85K

+17.96%

Mr. Vittorio Nisita

Executive Vice President, Head of Enterprise Services & Solutions

41.33K

+26.65%

Ms. Rochelle B. (Shelly) Lazarus

Independent Director

633.00

Ms. Shalini Sharp

Independent Director

2.00

Ms. Ramona A. Sequeira

Independent Director

Mr. Robert A. (Bob) Essner

Lead Independent Director

Ms. Grace M. Puma Whiteford

Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Matthew M. (Matt) Walsh

Chief Financial Officer, Executive Vice President

144.48K

+8.57%

Ms. Rachel A. Stahler

Executive Vice President, Chief Digital and Growth Officer

71.89K

+18.29%

Mr. Aaron Falcione

Chief Human Resources Officer, Executive Vice President

59.92K

+10.11%

Mr. Kirke Weaver

Executive Vice President, General Counsel, Corporate Secretary

52.85K

+17.96%

Mr. Vittorio Nisita

Executive Vice President, Head of Enterprise Services & Solutions

41.33K

+26.65%

Ms. Rochelle B. (Shelly) Lazarus

Independent Director

633.00

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Women’s Health

462.00M

28.98%

Cardiovascular

283.00M

17.75%

Non-Opioid Pain, Bone and Dermatology

250.00M

15.68%

Respiratory

220.00M

13.80%

Other

206.00M

12.92%

Biosimilars

173.00M

10.85%

地域別USD

会社名

収益

比率

Europe and Canada

419.00M

26.29%

United States

414.00M

25.97%

Latin America, Middle East, Russia and Africa

285.00M

17.88%

Asia Pacific and Japan

250.00M

15.68%

China

204.00M

12.80%

Other

22.00M

1.38%

事業別

地域別

事業別USD

会社名

収益

比率

Women’s Health

462.00M

28.98%

Cardiovascular

283.00M

17.75%

Non-Opioid Pain, Bone and Dermatology

250.00M

15.68%

Respiratory

220.00M

13.80%

Other

206.00M

12.92%

Biosimilars

173.00M

10.85%

株主

更新時刻: Sun, Nov 16

株主統計

種類

株主統計

比率

The Vanguard Group, Inc.

13.76%

BlackRock Institutional Trust Company, N.A.

10.68%

MFS Investment Management

3.63%

State Street Investment Management (US)

3.59%

LSV Asset Management

3.01%

他の

65.33%

株主統計

比率

The Vanguard Group, Inc.

13.76%

BlackRock Institutional Trust Company, N.A.

10.68%

MFS Investment Management

3.63%

State Street Investment Management (US)

3.59%

LSV Asset Management

3.01%

他の

65.33%

種類

株主統計

比率

Investment Advisor

47.62%

Investment Advisor/Hedge Fund

20.77%

Hedge Fund

4.75%

Pension Fund

2.56%

Research Firm

2.06%

Bank and Trust

0.92%

Sovereign Wealth Fund

0.86%

Individual Investor

0.36%

Venture Capital

0.04%

他の

20.06%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

1485

219.88M

84.58%

-37.41M

2025Q2

1527

205.34M

78.98%

-50.49M

2025Q1

1611

213.21M

82.04%

-52.34M

2024Q4

1647

218.39M

84.67%

-40.43M

2024Q3

1625

211.80M

82.26%

-47.57M

2024Q2

1676

208.67M

81.14%

-51.47M

2024Q1

1700

205.29M

80.30%

-45.21M

2023Q4

1767

202.90M

79.38%

-24.07M

2023Q3

1835

205.61M

80.45%

-25.35M

2023Q2

2016

205.94M

80.75%

-21.55M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

The Vanguard Group, Inc.

32.15M

12.37%

+2.54M

+8.57%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

28.28M

10.88%

-627.34K

-2.17%

Jun 30, 2025

MFS Investment Management

10.11M

3.89%

-469.39K

-4.44%

Jun 30, 2025

State Street Investment Management (US)

9.52M

3.66%

+540.48K

+6.02%

Jun 30, 2025

LSV Asset Management

7.99M

3.07%

+8.69K

+0.11%

Jun 30, 2025

Geode Capital Management, L.L.C.

4.40M

1.69%

-121.50K

-2.69%

Jun 30, 2025

Millennium Management LLC

9.09M

3.5%

+8.11M

+829.74%

Jun 30, 2025

AQR Capital Management, LLC

3.25M

1.25%

+1.88M

+136.10%

Jun 30, 2025

Gotham Asset Management, LLC

2.71M

1.04%

+1.31M

+93.22%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.63M

1.78%

+459.24K

+11.02%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 1.03B 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

Nov 10, 2025

OGN.NB Final Cash Dividend of gross USD 0.02 paid on Dec 11, 2025 going ex on Nov 20, 2025

Nov 20, 2025

Dec 11, 2025

Nov 20, 2025

Aug 05, 2025

OGN.NB Interim Cash Dividend of gross USD 0.02 paid on Sep 11, 2025 going ex on Aug 15, 2025

Aug 15, 2025

Sep 11, 2025

Aug 15, 2025

May 01, 2025

OGN.NB Interim Cash Dividend of gross USD 0.02 paid on Jun 12, 2025 going ex on May 12, 2025

May 12, 2025

Jun 12, 2025

May 12, 2025

Feb 13, 2025

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 13, 2025 going ex on Feb 24, 2025

Feb 24, 2025

Mar 13, 2025

Feb 24, 2025

Oct 31, 2024

OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 12, 2024 going ex on Nov 12, 2024

Nov 12, 2024

Dec 12, 2024

Nov 12, 2024

Aug 06, 2024

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Sep 12, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Sep 12, 2024

Aug 16, 2024

May 02, 2024

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Jun 13, 2024 going ex on May 10, 2024

May 13, 2024

Jun 13, 2024

May 10, 2024

Feb 15, 2024

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 14, 2024 going ex on Feb 23, 2024

Feb 26, 2024

Mar 14, 2024

Feb 23, 2024

Nov 02, 2023

OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 14, 2023 going ex on Nov 10, 2023

Nov 13, 2023

Dec 14, 2023

Nov 10, 2023

Aug 08, 2023

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Sep 14, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 14, 2023

Aug 17, 2023

詳細を見る

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

よくある質問

Organon & Coの上位5名の株主は誰ですか？



Organon & Coの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は32.15M株を保有しており、これは全体の12.37%に相当します。
BlackRock Institutional Trust Company, N.A.は28.28M株を保有しており、これは全体の10.88%に相当します。
MFS Investment Managementは10.11M株を保有しており、これは全体の3.89%に相当します。
State Street Investment Management (US)は9.52M株を保有しており、これは全体の3.66%に相当します。
LSV Asset Managementは7.99M株を保有しており、これは全体の3.07%に相当します。